1. Product Overview
2. Research Methodology
3.
Executive Summary
4.
Voice of Customer
5.
Global Oncology Drugs Market Outlook
5.1. Market Size &
Forecast
5.1.1.
By Value
5.2. Market Share &
Forecast
5.2.1.
By Drug Type (Cytotoxic Drugs, Targeted Drugs,
Hormonal Drugs)
5.2.2.
By Therapy (Chemotherapy, Targeted Therapy,
Immunotherapy (Biologic Therapy), Hormonal Therapy, Others)
5.2.3.
By Drug Therapy (Adjuvant, Neoadjuvant and
Concurrent)
5.2.4.
By Route of Administration (Oral, Intravenous,
Subcutaneous, Others)
5.2.5.
By Gender (Male, Female)
5.2.6.
By Cancer Type (Lung Cancer, Stomach Cancer,
Colorectal Cancer, Breast Cancer, Prostate Cancer, Liver Cancer, Esophagus
Cancer, Cervical Cancer, Kidney Cancer, Bladder Cancer, Others)
5.2.7.
By Distribution Channel (Hospital Pharmacies,
Retail Pharmacies, Online Pharmacies, Government Hospitals)
5.2.8.
By Company (2019)
5.2.9.
By Region
5.3.
Market Attractiveness Index
6.
Asia-Pacific Oncology Drugs Market Outlook
6.1. Market Size &
Forecast
6.1.1.
By Value
6.2. Market Share &
Forecast
6.2.1.
By Drug Type
6.2.2.
By Therapy
6.2.3.
By Drug Therapy
6.2.4.
By Route of Administration
6.2.5.
By Gender
6.2.6.
By Cancer Type
6.2.7.
By Country
6.3. Asia-Pacific: Country
Analysis
6.3.1.
China Oncology Drugs Market Outlook
6.3.1.1.
Market Size & Forecast
6.3.1.1.1.
By Value
6.3.1.2.
Market Share & Forecast
6.3.1.2.1.
By Drug Type
6.3.1.2.2.
By Therapy
6.3.1.2.3.
By Drug Therapy
6.3.1.2.4.
By Route of Administration
6.3.1.2.5.
By Gender
6.3.1.2.6.
By Cancer Type
6.3.2.
India Oncology Drugs Market Outlook
6.3.2.1.
Market Size & Forecast
6.3.2.1.1.
By Value
6.3.2.2.
Market Share & Forecast
6.3.2.2.1.
By Drug Type
6.3.2.2.2.
By Therapy
6.3.2.2.3.
By Drug Therapy
6.3.2.2.4.
By Route of Administration
6.3.2.2.5.
By Gender
6.3.2.2.6.
By Cancer Type
6.3.3.
Japan Oncology Drugs Market Outlook
6.3.3.1.
Market Size & Forecast
6.3.3.1.1.
By Value
6.3.3.2.
Market Share & Forecast
6.3.3.2.1.
By Drug Type
6.3.3.2.2.
By Therapy
6.3.3.2.3.
By Drug Therapy
6.3.3.2.4.
By Route of Administration
6.3.3.2.5.
By Gender
6.3.3.2.6.
By Cancer Type
6.3.4.
South Korea Oncology Drugs Market Outlook
6.3.4.1.
Market Size & Forecast
6.3.4.1.1.
By Value
6.3.4.2.
Market Share & Forecast
6.3.4.2.1.
By Drug Type
6.3.4.2.2.
By Therapy
6.3.4.2.3.
By Drug Therapy
6.3.4.2.4.
By Route of Administration
6.3.4.2.5.
By Gender
6.3.4.2.6.
By Cancer Type
6.3.5.
Singapore Oncology Drugs Market Outlook
6.3.5.1.
Market Size & Forecast
6.3.5.1.1.
By Value
6.3.5.2.
Market Share & Forecast
6.3.5.2.1.
By Drug Type
6.3.5.2.2.
By Therapy
6.3.5.2.3.
By Drug Therapy
6.3.5.2.4.
By Route of Administration
6.3.5.2.5.
By Gender
6.3.5.2.6.
By Cancer Type
6.3.6.
Australia Oncology Drugs Market Outlook
6.3.6.1.
Market Size & Forecast
6.3.6.1.1.
By Value
6.3.6.2.
Market Share & Forecast
6.3.6.2.1.
By Drug Type
6.3.6.2.2.
By Therapy
6.3.6.2.3.
By Drug Therapy
6.3.6.2.4.
By Route of Administration
6.3.6.2.5.
By Gender
6.3.6.2.6.
By Cancer Type
7.
Europe Oncology Drugs Market Outlook
7.1. Market Size &
Forecast
7.1.1.
By Value
7.2. Market Share &
Forecast
7.2.1.
By Drug Type
7.2.2.
By Therapy
7.2.3.
By Drug Therapy
7.2.4.
By Route of Administration
7.2.5.
By Gender
7.2.6.
By Cancer Type
7.2.7.
By Country
7.3. Europe: Country Analysis
7.3.1.
France Oncology Drugs Market Outlook
7.3.1.1.
Market Size & Forecast
7.3.1.1.1.
By Value
7.3.1.2.
Market Share & Forecast
7.3.1.2.1.
By Drug Type
7.3.1.2.2.
By Therapy
7.3.1.2.3.
By Drug Therapy
7.3.1.2.4.
By Route of Administration
7.3.1.2.5.
By Gender
7.3.1.2.6.
By Cancer Type
7.3.2.